StockData
IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Immix Biopharma, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$8.22+0.24 (+3.01%)

Close on Oct 19, 2026

Market cap
$524.20M
P/E (TTM)
–
Dividend yield
–

SEC filings

40 of Immix Biopharma's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KSep 29, 2026Sep 30, 2026SEC EDGAR
Current report8-KSep 29, 2026Sep 29, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 7, 2026SEC EDGAR
Current report8-KJul 20, 2026Jul 20, 2026SEC EDGAR
Current report8-KMay 22, 2026May 29, 2026SEC EDGAR
Current report8-KMay 21, 2026May 21, 2026SEC EDGAR
Current report8-KMay 21, 2026May 21, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 7, 2026SEC EDGAR
Proxy statementDEF 14AApr 6, 2026Apr 6, 2026SEC EDGAR
Current report8-KMar 30, 2026Mar 30, 2026SEC EDGAR
Annual report, amended10-K/ADec 31, 2025Mar 27, 2026SEC EDGAR
Current report8-KMar 25, 2026Mar 25, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 25, 2026SEC EDGAR
Current report8-KDec 7, 2025Dec 8, 2025SEC EDGAR
Current report8-KDec 7, 2025Dec 8, 2025SEC EDGAR
Current report8-KNov 26, 2025Nov 26, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 7, 2025SEC EDGAR
Current report8-KSep 5, 2025Sep 8, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 8, 2025SEC EDGAR
Current report8-KJun 20, 2025Jun 23, 2025SEC EDGAR
Current report8-KJun 3, 2025Jun 3, 2025SEC EDGAR
Quarterly report, amended10-Q/AMar 31, 2025May 19, 2025SEC EDGAR
Annual report, amended10-K/ADec 31, 2024May 19, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 8, 2025SEC EDGAR
Proxy statementDEF 14AApr 29, 2025Apr 30, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 25, 2025SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 12, 2024SEC EDGAR
Quarterly report10-QJun 30, 2024Aug 12, 2024SEC EDGAR
Current report8-KJul 25, 2024Jul 26, 2024SEC EDGAR
Current report8-KJul 17, 2024Jul 22, 2024SEC EDGAR
Current report8-KJun 11, 2024Jun 14, 2024SEC EDGAR
Current report8-KMay 20, 2024May 20, 2024SEC EDGAR
Quarterly report10-QMar 31, 2024May 9, 2024SEC EDGAR
Proxy statementDEF 14AApr 29, 2024Apr 29, 2024SEC EDGAR
Annual report10-KDec 31, 2023Mar 29, 2024SEC EDGAR
Current report8-KFeb 6, 2024Feb 6, 2024SEC EDGAR
Current report8-KFeb 5, 2024Feb 5, 2024SEC EDGAR
Quarterly report10-QSep 30, 2023Nov 13, 2023SEC EDGAR
Current report8-KAug 22, 2023Aug 22, 2023SEC EDGAR
Quarterly report10-QJun 30, 2023Aug 11, 2023SEC EDGAR